Research Study for adults with Ulcerative Colitis

IRB/UVA Tracking #
Principal Investigator
Behm Brian,
Harriette Wheatley
Contact Email
Contact Phone
Official Trial Title
Entyvio (vedolizumab) long-term safety study: An international observational prospective cohort study comparing vedolizumab to other biologic agents in patients with ulcerative colitis or Crohn’s Disease. (MLN-0002-401)
Study Description

The Department of Gastroenterology (GI) is conducting an observational research study, collecting health information from adults with Inflammatory Bowel Disease (IBD). To be eligible, you must be 18 years or older and are about to begin taking medication to treat your IBD. Participation includes review of medical records and completing questionnaires. There will be 15 study visits (alternating in person and by phone call) over 7 years.


$20 per visit